Bupivacaine Spinal 0,5% Heavy - titration — Competitive Intelligence Brief

Bupivacaine Spinal 0,5% Heavy - titration (Bupivacaine Spinal 0,5% Heavy - titration) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Local anesthetic (amide class). Area: Anesthesia.

marketed Local anesthetic (amide class) Voltage-gated sodium channels (Nav) Anesthesia Small molecule

Target snapshot

Bupivacaine Spinal 0,5% Heavy - titration (Bupivacaine Spinal 0,5% Heavy - titration) — Centre of Postgraduate Medical Education. Bupivacaine is a local anesthetic that blocks sodium channels in nerve cell membranes, preventing the initiation and propagation of action potentials.

Comparator set (6 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Bupivacaine Spinal 0,5% Heavy - titration TARGET	Bupivacaine Spinal 0,5% Heavy - titration	Centre of Postgraduate Medical Education	marketed	Local anesthetic (amide class)	Voltage-gated sodium channels (Nav)
local infiltration of liposomal bupivacaine	local infiltration of liposomal bupivacaine	TriHealth Inc.	marketed	Local anesthetic (amide class)	Voltage-gated sodium channels
Prilocaine 0.66%	Prilocaine 0.66%	Bozyaka Training and Research Hospital	marketed	Local anesthetic (amide class)	Voltage-gated sodium channels
Hyperbaric Levobupivacaine 0.75%	Hyperbaric Levobupivacaine 0.75%	Fundacion Clinica Valle del Lili	marketed	Local anesthetic (amide class)	Voltage-gated sodium channels
Bupivacaine %0.25 (isobaric)	Bupivacaine %0.25 (isobaric)	Bursa City Hospital	marketed	Local anesthetic (amide class)	Voltage-gated sodium channels
Bupivacain (Postoperative)	Bupivacain (Postoperative)	Başakşehir Çam & Sakura City Hospital	marketed	Local anesthetic (amide class)	Voltage-gated sodium channels
Lidocaine Ropivacaine	Lidocaine Ropivacaine	TriHealth Inc.	marketed	Local anesthetic (amide class)	Voltage-gated sodium channels

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Local anesthetic (amide class) class)

1. Ain Shams University · 2 drugs in this class
2. Başakşehir Çam & Sakura City Hospital · 2 drugs in this class
3. TriHealth Inc. · 2 drugs in this class
4. Centre of Postgraduate Medical Education · 2 drugs in this class
5. Bozyaka Training and Research Hospital · 2 drugs in this class
6. Complejo Hospitalario Universitario de Granada · 1 drug in this class
7. Clinique Saint-Jean, Bruxelles · 1 drug in this class
8. Hospital Clínico Universitario de Valencia · 1 drug in this class
9. Fundacion Clinica Valle del Lili · 1 drug in this class
10. Federal University of Minas Gerais · 1 drug in this class